{"id":"lanatoside-c","rwe":[{"pmid":"41826982","year":"2026","title":"Targeting MYC in T-Cell lymphoma via epigenetic modulation with a small-molecule inhibitor.","finding":"","journal":"Molecular cancer","studyType":"Clinical Study"},{"pmid":"30725648","year":"2026","title":"Cardioactive Steroid Toxicity.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"41649863","year":"2026","title":"Screening of FDA-approved drugs using a recombinant Cedar virus to improve treatment options for Nipah virus infection.","finding":"","journal":"The Journal of general virology","studyType":"Clinical Study"},{"pmid":"41616397","year":"2026","title":"Magnetic C(18)-modified mesoporous silica as an efficient adsorbent for dispersive solid phase microextraction of cardiac glycosides in human plasma.","finding":"","journal":"Journal of chromatography. A","studyType":"Clinical Study"},{"pmid":"41606129","year":"2026","title":"Lanatoside C ameliorates DSS-induced colitis with improved intestinal barrier integrity and reduced M1 macrophage polarization.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"}],"tags":[{"label":"lanatoside C","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"C01AA06","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"lanatigen c","offLabel":[],"synonyms":["lanatoside C","allocor","cedilanid","ceglunat","ceglunate","celadigal","celanid","celanide","cetosanol","Digilanide C","Digilanogen C","isolanid","isolanide","Lanatigen C"],"timeline":[],"approvals":[],"brandName":"Lanatigen C","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"lanatoside C","explanation":"Imagine your heart cells have a pump that helps them relax and contract. Lanatoside C blocks this pump, making the cells work harder and contract more strongly, which can help improve heart function. However, this can also lead to side effects if not used carefully.","oneSentence":"Lanatoside C works by inhibiting the sodium-potassium pump in cardiac cells, leading to increased contractility and reduced heart rate.","technicalDetail":"Lanatoside C acts as a cardiac glycoside by competitively inhibiting the sodium-potassium ATPase pump, leading to increased intracellular sodium and calcium levels, which in turn increases contractility and reduces heart rate."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1543","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LANATOSIDE C","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:04:07.779240","biosimilars":[],"competitors":[{"drugName":"acetyldigitoxin","drugSlug":"acetyldigitoxin","fdaApproval":"1975-04-24","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"digitoxin","drugSlug":"digitoxin","fdaApproval":"","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"digoxin","drugSlug":"digoxin","fdaApproval":"1975-10-24","genericCount":14,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"deslanoside","drugSlug":"deslanoside","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"lanatoside c","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"acetyldigitoxin","brandName":"acetyldigitoxin","genericName":"acetyldigitoxin","approvalYear":"1975","relationship":"same-class"},{"drugId":"digitoxin","brandName":"digitoxin","genericName":"digitoxin","approvalYear":"","relationship":"same-class"},{"drugId":"digoxin","brandName":"digoxin","genericName":"digoxin","approvalYear":"1975","relationship":"same-class"},{"drugId":"deslanoside","brandName":"deslanoside","genericName":"deslanoside","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"000594","UNII":"5RR3JFZ771","CHEBI":"CHEBI:135898","INN_ID":"393","RXNORM":"27929","UMLSCUI":"C0063986","ChEMBL_ID":"CHEMBL506569","KEGG_DRUG":"D01972","DRUGBANK_ID":"DB13467","PUBCHEM_CID":"656630","SNOMEDCT_US":"387338006","MESH_SUPPLEMENTAL_RECORD_UI":"C018548"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":265,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C01AA06","allCodes":["C01AA06"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 13","pmid":"41826982","title":"Targeting MYC in T-Cell lymphoma via epigenetic modulation with a small-molecule inhibitor.","journal":"Molecular cancer"},{"date":"2026 Jan","pmid":"30725648","title":"Cardioactive Steroid Toxicity.","journal":""},{"date":"2026 Feb","pmid":"41649863","title":"Screening of FDA-approved drugs using a recombinant Cedar virus to improve treatment options for Nipah virus infection.","journal":"The Journal of general virology"},{"date":"2026 Mar 29","pmid":"41616397","title":"Magnetic C(18)-modified mesoporous silica as an efficient adsorbent for dispersive solid phase microextraction of cardiac glycosides in human plasma.","journal":"Journal of chromatography. A"},{"date":"2026 Jan 28","pmid":"41606129","title":"Lanatoside C ameliorates DSS-induced colitis with improved intestinal barrier integrity and reduced M1 macrophage polarization.","journal":"Scientific reports"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lanatoside C, also known as Lanatigen C, is a small molecule drug in the lanatoside C class. It is a cardiac glycoside that works by inhibiting the sodium-potassium pump in cardiac cells, leading to increased contractility and reduced heart rate. However, due to the lack of available information, its target, approved indications, and commercial status are unknown. Further research is needed to determine its efficacy and safety profile. As a result, it is not possible to provide a comprehensive summary of its key safety considerations.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}